See also this year's filing and all EDGAR filings for this company.
PDF Report 0001260990_2013_Oncternal_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001260990, Oncternal Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 56,815,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 507,000 |
| 3 | remainder_Assets | 452,000 |
| 4 | LiabilitiesCurrent | 9,495,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 10,845,000 |
| 9 | ResearchAndDevelopmentExpense | 38,887,000 |
| 10 | remainder_Expenses | -8,821,000 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 13,836,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 57,774,000 |
| 1 | Liabilities | 9,495,000 |
| 2 | Expenses | 40,911,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 48,279,000 |
| 5 | NetIncome | -27,075,000 |
| 6 | ComprehensiveNetIncome | -27,075,000 |
| 7 | BaseVar | 61,008,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.32 |
| 9 | EconomicCapitalRatio | 3.24 |
Edgar->Model Mapping
Feature Distribution
Change over Time
